Dopamine agonists for the treatment of cocaine dependence.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS(2015)
Abstract
Current evidence from RCTs does not support the use of dopamine agonists for treating cocaine misuse. This absence of evidence may leave to clinicians the alternative of balancing the possible benefits against the potential adverse effects of the treatment. Even the potential benefit of combining a dopamine agonist with a more potent psychosocial intervention, which was suggested by the previous Cochrane Review (Soares 2003), is not supported by the results of this Cochrane Review update.
MoreTranslated text
Key words
Amantadine [therapeutic use],Bromocriptine [therapeutic use],Cocaine-RelatedDisorders [*drug therapy],Depression [drug therapy],Dopamine Agonists [*therapeutic use],Levodopa [therapeutic use],Randomized Controlled Trials as Topic,Humans
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined